Ribon Therapeutics, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2017-10-10. The offering totals $20.0M, of which $20.0M was reported sold. Industry: Biotechnology.
Showing 25 of 27 people.
| Name | Role | Location |
|---|---|---|
| Laurence Lasky | Director | Lexington, MA |
| Jonathan Root | Director | Aliso Viejo, CA |
| Eyal Lifschitz | Director | Or Yehuda, L3 |
| Emma Reeve | Director | Norfolk, VA |
| Jeff Goater | Director | New York, NY |
| Laura Brass | Director | BOSTON, MA |
| Paul Brannelly | Executive Officer | Cambridge, MA |
| James Audia | Director | Cambridge, MA |
| Jodie Morrison | Director | Cambridge, MA |
| Cameron Wheeler | Director | Cambridge, MA |
| Prakash Raman | Director | Cambridge, MA |
| Prakash Raman | Executive Officer | Cambridge, MA |
| Gary Sutton | Executive Officer | Cambridge, MA |
| Marian M Nakada | Director | Cambridge, MA |
| Svennilson Peter | Director | Cambridge, MA |
| Edward M Stewart | Executive Officer | Cambridge, MA |
| Cameron M Wheeler | Director | Cambridge, MA |
| James M Audia | Director | Cambridge, MA |
| Victoria M Richon | Director | Cambridge, MA |
| Victoria M Richon | Executive Officer | Cambridge, MA |
| Emma M Reeve | Director | Cambridge, MA |
| Jodie M Morrison | Director | Cambridge, MA |
| Laura M Brass | Director | Cambridge, MA |
| Jonathan M Root | Director | Cambridge, MA |
| Anja M Koenig | Director | Lexington, MA |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2022-12-22 | D | $25.0M | $25.0M |
| 2021-06-14 | D | $60.2M | $25.2M |
| 2019-01-04 | D | $65.0M | $25.4M |
| 2016-11-23 | D/A | $23.5M | $23.5M |
| 2015-12-17 | D | $21.0M | $10.0M |